Icariin prevents cytokine‑induced β‑cell death by inhibiting NF‑κB signaling
- Authors:
- Shao Zhong
- Jing Ge
- Jiang‑Yi Yu
-
Affiliations: Department of Endocrinology, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, P.R. China, Department of Endocrinology, Jiangsu Province Hospital of Traditional Chinese Medicine, Affiliated Hospital of Nanjing University of Traditional Chinese Medicine, Nanjing, Jiangsu 210029, P.R. China - Published online on: July 20, 2018 https://doi.org/10.3892/etm.2018.6502
- Pages: 2756-2762
This article is mentioned in:
Abstract
 |
 |
 |
 |
|
Philippe J and Raccah D: Treating type 2 diabetes: How safe are current therapeutic agents? Int J Clin Pract. 63:321–332. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Akkati S, Sam KG and Tungha G: Emergence of promising therapies in diabetes mellitus. J Clin Pharmacol. 51:796–804. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
King H, Aubert RE and Herman WH: Global burden of diabetes, 1995–2025: Prevalence, numerical estimates and projections. Diabetes Care. 21:1414–1431. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
American Diabetes Association, : Diagnosis and classification of diabetes mellitus. Diabetes Care. 31 Suppl 1:S55–S60. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Patterson CC, Gyurus E, Rosenbauer J, Cinek O, Neu A, Schober E, Parslow RC, Joner G, Svensson J, Castell C, et al: Trends in childhood type 1 diabetes incidence in Europe during 1989–2008: Evidence of non-uniformity over time in rates of increase. Diabetologia. 55:2142–2147. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Patterson CC, Dahlquist GG, Gyurus E, Green A and Soltész G; EURODIAB Study Group, : Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study. Lancet. 373:2027–2033. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Redondo MJ, Jeffrey J, Fain PR, Eisenbarth GS and Orban T: Concordance for islet autoimmunity among monozygotic twins. N Engl J Med. 359:2849–2850. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Davidson MH: Cardiovascular risk factors in a patient with diabetes mellitus and coronary artery disease: Therapeutic approaches to improve outcomes: Perspectives of a preventive cardiologist. Am J Cardiol. 110 9 Suppl:43B–49B. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Robertson RP: Islet transplantation a decade later and strategies for filling a half-full glass. Diabetes. 59:1285–1291. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Ehses JA, Perren A, Eppler E, Ribaux P, Pospisilik JA, Maor-Cahn R, Gueripel X, Ellingsgaard H, Schneider MK, Biollaz G, et al: Increased number of islet-associated macrophages in type 2 diabetes. Diabetes. 56:2356–2370. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Eizirik DL, Sammeth M, Bouckenooghe T, Bottu G, Sisino G, Igoillo-Esteve M, Ortis F, Santin I, Colli ML, Barthson J, et al: The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines. PLoS Genet. 8:e10025522012. View Article : Google Scholar : PubMed/NCBI | |
|
Wellen KE and Hotamisligil GS: Inflammation, stress and diabetes. J Clin Invest. 115:1111–1119. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Arif S, Moore F, Marks K, Bouckenooghe T, Dayan CM, Planas R, Vives-Pi M, Powrie J, Tree T, Marchetti P, et al: Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and promotes cytokine-mediated beta-cell death. Diabetes. 60:2112–2119. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Atkinson MA, Eisenbarth GS and Michels AW: Type 1 diabetes. Lancet. 383:69–82. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Baldwin AC, Green CD, Olson LK, Moxley MA and Corbett JA: A role for aberrant protein palmitoylation in FFA-induced ER stress and beta-cell death. Am J Physiol Endocrinol Metab. 302:E1390–E1398. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Imai Y, Dobrian AD, Weaver JR, Butcher MJ, Cole BK, Galkina EV, Morris MA, Taylor-Fishwick DA and Nadler JL: Interaction between cytokines and inflammatory cells in islet dysfunction, insulin resistance and vascular disease. Diabetes Obes Metab. 15 Suppl 3:S117–S129. 2013. View Article : Google Scholar | |
|
Cnop M, Welsh N, Jonas JC, Jörns A, Lenzen S and Eizirik DL: Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes. 54 Suppl 2:S97–S107. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Eizirik DL, Colli ML and Ortis F: The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev Endocrinol. 5:219–226. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Corbett JA and McDaniel ML: Does nitric oxide mediate autoimmune destruction of beta-cells? Possible therapeutic interventions in IDDM. Diabetes. 41:897–903. 1992. View Article : Google Scholar : PubMed/NCBI | |
|
Chen Y, Huang JH, Ning Y and Shen ZY: Icariin and its pharmaceutical efficacy: research progress of molecular mechanism. Zhong Xi Yi Jie He Xue Bao. 9:1179–1184. 2011.(In Chinese). View Article : Google Scholar : PubMed/NCBI | |
|
Wu JF, Dong JC and Xu CQ: Effects of icariin on inflammation model stimulated by lipopolysaccharide in vitro and in vivo. Zhongguo Zhong Xi Yi Jie He Za Zhi. 29:330–334. 2009.(In Chinese). PubMed/NCBI | |
|
Liu MH, Sun JS, Tsai SW, Sheu SY and Chen MH: Icariin protects murine chondrocytes from lipopolysaccharide-induced inflammatory responses and extracellular matrix degradation. Nutr Res. 30:57–65. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Xu CQ, Liu BJ, Wu JF, Xu YC, Duan XH, Cao YX and Dong JC: Icariin attenuates LPS-induced acute inflammatory responses: involvement of PI3K/Akt and NF-kappaB signaling pathway. Eur J Pharmacol. 642:146–153. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Bae UJ, Lee da Y, Song MY, Lee SM, Park JW, Ryu JH and Park BH: A prenylated flavan from Broussonetia kazinoki prevents cytokine-induced beta-cell death through suppression of nuclear factor-kB activity. Biol Pharm Bull. 34:1026–1031. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Saldeen J: Cytokines induce both necrosis and apoptosis via a common Bcl-2-inhibitable pathway in rat insulin-producing cells. Endocrinology. 141:2003–2010. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS and Dixit VM: Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly (ADP-ribose) polymerase. Cell. 81:801–809. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Heimberg H, Heremans Y, Jobin C, Leemans R, Cardozo AK, Darville M and Eizirik DL: Inhibition of cytokine-induced NF-kappaB activation by adenovirus-mediated expression of a NF-kappaB super-repressor prevents beta-cell apoptosis. Diabetes. 50:2219–2224. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Eldor R, Yeffet A, Baum K, Doviner V, Amar D, Ben-Neriah Y, Christofori G, Peled A, Carel JC, Boitard C, et al: Conditional and specific NF-kappaB blockade protects pancreatic beta cells from diabetogenic agents. Proc Natl Acad Sci USA. 103:5072–5077. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Gong Y, Shi J, Xie GY, Liu HR and Qi MY: Amelioration of icariin for the epididymis impairment induced by streptozocin (STZ) in rats. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 29:47–50. 2013.(In Chinese). PubMed/NCBI | |
|
Zhang WP, Bai XJ, Zheng XP, Xie XL and Yuan ZY: Icariin attenuates the enhanced prothrombotic state in atherosclerotic rabbits independently of its lipid-lowering effects. Planta Med. 79:731–736. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Xin H, Zhou F, Liu T, Li GY, Liu J, Gao ZZ, Bai GY, Lu H and Xin ZC: Icariin ameliorates streptozotocin-induced diabetic retinopathy in vitro and in vivo. Int J Mol Sci. 13:866–878. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Qi MY, Kai C, Liu HR, Su YH and Yu SQ: Protective effect of Icariin on the early stage of experimental diabetic nephropathy induced by streptozotocin via modulating transforming growth factor beta1 and type IV collagen expression in rats. J Ethnopharmacol. 138:731–736. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Lu YF, Xu YY, Jin F, Wu Q, Shi JS and Liu J: Icariin is a PPARα activator inducing lipid metabolic gene expression in mice. Molecules. 19:18179–18191. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Tran B, Oliver S, Rosa J and Galassetti P: Aspects of inflammation and oxidative stress in pediatric obesity and type 1 diabetes: An overview of ten years of studies. Exp Diabetes Res. 2012:6836802012. View Article : Google Scholar : PubMed/NCBI | |
|
Devaraj S, Dasu MR, Rockwood J, Winter W, Griffen SC and Jialal I: Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: Further evidence of a proinflammatory state. J Clin Endocrinol Metab. 93:578–583. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Devaraj S, Glaser N, Griffen S, Wang-Polagruto J, Miguelino E and Jialal I: Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes. Diabetes. 55:774–779. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Yamagishi S: Advanced glycation end products and receptor-oxidative stress system in diabetic vascular complications. Ther Apher Dial. 13:534–539. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Maritim AC, Sanders RA and Watkins JB III: Diabetes, oxidative stress and antioxidants: A review. J Biochem Mol Toxicol. 17:24–38. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Chen Y, Sun T, Wu J, Kalionis B, Zhang C, Yuan D, Huang J, Cai W, Fang H and Xia S: Icariin intervenes in cardiac inflammaging through upregulation of SIRT6 enzyme activity and inhibition of the NF-Kappa B pathway. Biomed Res Int. 2015:8959762015.PubMed/NCBI | |
|
Zhou H, Yuan Y, Liu Y, Ni J, Deng W, Bian ZY, Dai J and Tang QZ: Icariin protects H9c2 cardiomyocytes from lipopolysaccharide-induced injury via inhibition of the reactive oxygen species-dependent c-Jun N-terminal kinases/nuclear factor-kB pathway. Mol Med Rep. 11:4327–4332. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Wei Y, Liu B, Sun J, Lv Y, Luo Q, Liu F and Dong J: Regulation of Th17/Treg function contributes to the attenuation of chronic airway inflammation by icariin in ovalbumin-induced murine asthma model. Immunobiology. 220:789–797. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Shen R, Deng W, Li C and Zeng G: A natural flavonoid glucoside icariin inhibits Th1 and Th17 cell differentiation and ameliorates experimental autoimmune encephalomyelitis. Int Immunopharmacol. 24:224–231. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Chi L, Gao W, Shu X and Lu X: A natural flavonoid glucoside, icariin, regulates Th17 and alleviates rheumatoid arthritis in a murine model. Mediators Inflamm. 2014:3920622014. View Article : Google Scholar : PubMed/NCBI | |
|
Li L, Sun J, Xu C, Zhang H, Wu J, Liu B and Dong J: Icariin ameliorates cigarette smoke induced inflammatory responses via suppression of NF-kB and modulation of GR in vivo and in vitro. PLoS One. 9:e1023452014. View Article : Google Scholar : PubMed/NCBI | |
|
Cui J, Zhu M, Zhu S, Wang G, Xu Y and Geng D: Inhibitory effect of icariin on Ti-induced inflammatory osteoclastogenesis. J Surg Res. 192:447–453. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Tao F, Qian C, Guo W, Luo Q, Xu Q and Sun Y: Inhibition of Th1/Th17 responses via suppression of STAT1 and STAT3 activation contributes to the amelioration of murine experimental colitis by a natural flavonoid glucoside icariin. Biochem Pharmacol. 85:798–807. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou J, Wu J, Chen X, Fortenbery N, Eksioglu E, Kodumudi KN, Pk EB, Dong J, Djeu JY and Wei S: Icariin and its derivative, ICT, exert anti-inflammatory, anti-tumor effects and modulate myeloid derived suppressive cells (MDSCs) functions. Int Immunopharmacol. 11:890–898. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Chen SR, Xu XZ, Wang YH, Chen JW, Xu SW, Gu LQ and Liu PQ: Icariin derivative inhibits inflammation through suppression of p38 mitogen-activated protein kinase and nuclear factor-kappaB pathways. Biol Pharm Bull. 33:1307–1313. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Hsieh TP, Sheu SY, Sun JS and Chen MH: Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-kB regulated HIF-1α and PGE (2) synthesis. Phytomedicine. 18:176–185. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Guo J, Li F, Wu Q, Lu Y and Shi J: Protective effects of icariin on brain dysfunction induced by lipopolysaccharide in rats. Phytomedicine. 17:950–955. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Grey ST, Longo C, Shukri T, Patel VI, Csizmadia E, Daniel S, Arvelo MB, Tchipashvili V and Ferran C: Genetic engineering of a suboptimal islet graft with A20 preserves beta cell mass and function. J Immunol. 170:6250–6256. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Xu HB and Huang ZQ: Icariin enhances endothelial nitric-oxide synthase expression on human endothelial cells in vitro. Vascul Pharmacol. 47:18–24. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Wo Y, Zhu D, Yu Y and Lou Y: Involvement of NF-kappaB and AP-1 activation in icariin promoted cardiac differentiation of mouse embryonic stem cells. Eur J Pharmacol. 586:59–66. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Zeng KW, Fu H, Liu GX and Wang XM: Icariin attenuates lipopolysaccharide-induced microglial activation and resultant death of neurons by inhibiting TAK1/IKK/NF-kappaB and JNK/p38 MAPK pathways. Int Immunopharmacol. 10:668–678. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Wu W, Pan C, Yu H, Gong H and Wang Y: Heparanase expression in gallbladder carcinoma and its correlation to prognosis. J Gastroenterol Hepatol. 23:491–497. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Yang L, Wang Y, Guo H and Guo M: Synergistic anti-cancer effects of icariin and temozolomide in glioblastoma. Cell Biochem Biophys. 71:1379–1385. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Han H, Xu B, Hou P, Jiang C, Liu L, Tang M, Yang X, Zhang Y and Liu Y: Icaritin sensitizes human glioblastoma cells to TRAIL-induced apoptosis. Cell Biochem Biophys. 72:533–542. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Y, Wei Y, Zhu Z, Gong W, Liu X, Hou Q, Sun Y, Chai J, Zou L and Zhou T: Icariin enhances radiosensitivity of colorectal cancer cells by suppressing NF-kB activity. Cell Biochem Biophys. 69:303–310. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Shi DB, Li XX, Zheng HT, Li DW, Cai GX, Peng JJ, Gu WL, Guan ZQ, Xu Y and Cai SJ: Icariin-mediated inhibition of NF-kB activity enhances the in vitro and in vivo antitumour effect of 5-fluorouracil in colorectal cancer. Cell Biochem Biophys. 69:523–530. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Gazdar AF, Chick WL, Oie HK, Sims HL, King DL, Weir GC and Lauris V: Continuous, clonal, insulin- and somatostatin-secreting cell lines established from a transplantable rat islet cell tumor. Proc Natl Acad Sci USA. 77:3519–3523. 1980. View Article : Google Scholar : PubMed/NCBI | |
|
Praz GA, Halban PA, Wollheim CB, Blondel B, Strauss AJ and Renold AE: Regulation of immunoreactive-insulin release from a rat cell line (RINm5F). Biochem J;. 210:345–352. 1983. View Article : Google Scholar : PubMed/NCBI |
